Statins, among the most commonly prescribed drugs worldwide, are cholesterol-lowering
agents used to manage and prevent cardiovascular and coronary heart diseases. Recently …

Venous thrombosis is a leading cause of morbidity and mortality in industrialized countries,
especially in the elderly. Many risk factors have been identified for venous thrombosis that …

Background This guideline addressed VTE prevention in hospitalized medical patients,
outpatients with cancer, the chronically immobilized, long-distance travelers, and those with …

Background About 20% of patients with unprovoked venous thromboembolism have a
recurrence within 2 years after the withdrawal of oral anticoagulant therapy. Extending …

Background Controversy persists regarding the extent of shared pathways between arterial
and venous thrombosis and whether treatments of known efficacy for one disease process …

Background Recommendations for venous thromboembolism (VTE) prophylaxis in patients
with inflammatory bowel disease (IBD) can be refined by incorporating patient-specific risk …

Deep venous thrombosis (DVT) is part of a spectrum of venous thromboembolic disorders
that includes superficial thrombophlebitis and pulmonary embolism. 1 DVT may be defined …

Background: D-dimer, a degradation product of cross-linked fibrin, is a marker for
hypercoagulability and thrombotic events. Moderately elevated levels of D-dimer are …

Background Efficacy of statins has been extensively studied, with much less information
reported on their unintended effects. Evidence from randomized controlled trials (RCTs) on …

Identification of individuals with ischemic stroke at particularly high risk of venous
thromboembolism (VTE) is crucial for targeted thromboprophylaxis. To guide clinical …